Evidence map›Paper›PMID 25383139›Full record

Trial reportOxidative medicine and cellular longevity2014

The role of oxidative stress and the effects of antioxidants on the incidence of infectious complications of chronic lymphocytic leukemia.

Amelia Maria Gaman, Ana-Maria Buga, Mihnea-Alexandru Gaman, Aurel Popa-Wagner

Open access · hybridAbstract readClinical Trial
In one paragraph

Trial report in Oxidative medicine and cellular longevity, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
0.6field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 38 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Phytochemical profile andAfrican health sciences · 2021
    Article
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Amelia Maria GamanResearch Center of Experimental and Clinical Medicine, University of Medicine and Pharmacy of Craiova, Romania ; Filantropia City Hospital of Craiova, Romania.
Ana-Maria BugaResearch Center of Experimental and Clinical Medicine, University of Medicine and Pharmacy of Craiova, Romania.
Mihnea-Alexandru GamanCarol Davila University of Medicine and Pharmacy, Bucharest, Romania.
Aurel Popa-WagnerResearch Center of Experimental and Clinical Medicine, University of Medicine and Pharmacy of Craiova, Romania ; Department of Psychiatry, University of Medicine Rostock, Gehlsheimerstrasse 20, 18147 Rostock, Germany.
University of Medicine and Pharmacy of Craiova · ROCarol Davila University of Medicine and Pharmacy · RO

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chronic lymphocytic leukemia (CLL) is characterized by a predominant humoral immune deficiency predisposing the patients to infections. Oxidative stress leads to an increased immunoglobulin k light chain production in B cells and contributes to the antibodies' deficiency and hypogammaglobulinemia. Aim of the Study. To evaluate the global oxidative status in patients with CLL and to determine whether the administration of antioxidants decreases complications due to infections. Patients and Method. We studied 84 patients with CLL stratified by Binet staging. Free oxygen radicals and antioxidant status were determined by the FORT and FORD test, respectively, at diagnosis and in the presence of infections. The patients were distributed in two groups: group A, treated only with antileukemic treatment, and group B, treated with antileukemic treatment and antioxidants. Results. By FORD and FORT assay, all patients had at diagnosis a low antioxidant capacity, and high levels of hydroperoxides. Infectious complications were more frequent in group A (B/C stages of disease) than in group B. Administrations of antioxidants stimulated the immune response and decreased infectious complications in CLL. Conclusions. Administrations of antioxidants and a healthy life style may improve the quality of life of patients with CLL and reduce the risk of infectious complications.

Indexed as

AgedAged, 80 and overAntioxidantsFemaleHumansIncidenceInfectionsLeukemia, Lymphocytic, Chronic, B-CellMaleMiddle AgedOxidative StressQuality of LifeReactive Oxygen SpeciesAntioxidantsReactive Oxygen Species

Identifiers

PMID25383139
PMCPMC4212632
OpenAlexW2132660642

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.